Pfizer bets on gene therapy as technology comes of age
Monday, December 8, 2014 - 11:40
in Mathematics & Economics
LONDON (Reuters) - Pfizer Inc is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks.